companydata.dkcompanydata.dk

Inwound ApS: Financial statements 2022

CVR: 39766612

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Inwound ApS (CVR 39766612) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -988,179 and a net result of DKK -2,340,952 compared with DKK -2,151,165 the year before. Equity in the 2022 report amounted to DKK -4,585,777. The company had 2 employees in the financial year.

Gross Profit
DKK -988,179
Profit/Loss
DKK -2,340,952
Equity
DKK -4,585,777
Total Assets
DKK 2,385,906
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--988 t.-2.3 mio.-4.6 mio.2
2021--857 t.-2.2 mio.-2.2 mio.3
2020--72 t.-508 t.-1.1 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Inwound ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Inwound ApS appoints new auditorOct 5, 2022

As of October 5, 2022, A/S PSE 17 NR. 1056 has been appointed auditor of Inwound ApS.

Auditor steps down at Inwound ApSOct 5, 2022

As of October 5, 2022, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Inwound ApS.

Sophia Sara Leth joins Inwound ApS as adm. dir.Sep 20, 2022

As of September 20, 2022, Sophia Sara Leth is registered as adm. dir. of Inwound ApS.

Janus Beierholm steps down as adm. dir. of Inwound ApSSep 20, 2022

As of September 20, 2022, Janus Beierholm has stepped down as adm. dir. of Inwound ApS.

Inwound ApS: The 2021 annual report is outJul 2, 2022

Inwound ApS has published its annual report for 2021. Gross profit came to DKK -856,634, and the net result was DKK -2,151,165.

Bjørn Broby Glavind leaves the board of Inwound ApSApr 29, 2022

As of April 29, 2022, Bjørn Broby Glavind has left the board of directors of Inwound ApS.

About Inwound ApS

Inwound ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named VulCur MedTech ApS. The management consists of Lasse Blirup Snejbjerg. The board consists of Carl Morten Bilbo (chair), Bent von Eitzen, Christopher Bromley and Lasse Blirup Snejbjerg. The company's owners include WINDING ROADS ApS, Akk Biotek Holding ApS and K Fischer Hansen ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -4,096,380 and a net result of DKK -7,706,800 compared with DKK -1,025,932 the year before. Equity in the 2025 report amounted to DKK 5,862,914.

Source: annual report 2025, Danish Business Authority

Other financial years